Zucker School of Medicine at Hofstra/Northwell (North Shore University Hospital/LIJ)
Gastroenterology fellowship · Manhasset, NY · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Donald & Barbara Zucker School of Medicine at Hofstra/Northwell's research in gastroenterology, which the program shares with other departments and affiliated hospitals.
About Donald & Barbara Zucker School of Medicine at Hofstra/Northwellinstitution-wide gastroenterology research
Gastroenterology publications from Donald & Barbara Zucker School of Medicine at Hofstra/Northwell + Northwell Health and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
41
works per year
25th of 77 gastroenterology fellowship programs
+60.3%
2-year growth
11th of 76 gastroenterology fellowship programs
10.1%
in top 10% of field (works before 2025)
63rd of 66 gastroenterology fellowship programs
33.0%
cited above world average
60th of 66 gastroenterology fellowship programs
Works per year · * 2026 so far
Hepatology · 136Gastroenterology · 82
Gastroenterology research topics at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
Papers in the window; each links to the list on OpenAlex.
- Hepatocellular Carcinoma Treatment and Prognosis 58
- Liver Disease and Transplantation 47
- Gastroesophageal reflux and treatments 21
- Gastrointestinal motility and disorders 20
- Gastrointestinal Bleeding Diagnosis and Treatment 17
- Hepatitis C virus research 13
- Inflammatory Bowel Disease 9
- Gastrointestinal Tumor Research and Treatment 8
Most cited at Donald & Barbara Zucker School of Medicine at Hofstra/Northwell since 2024
All gastroenterology papers there on OpenAlex
- Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysisMohammad Saeid Rezaee Zavareh et al. · Journal of Hepatology · 2024 · PubMed · cited 117
- Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSCYujia Xia et al. · Hepatology · 2024 · PubMed · cited 113
- Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLDXiaodong Zhou et al. · Journal of Hepatology · 2025 · PubMed · cited 60
- Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023Soeun Kim et al. · The Lancet. Gastroenterology & hepatology · 2026 · PubMed · cited 55
- Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLDXiaodong Zhou et al. · Clinical Gastroenterology and Hepatology · 2025 · PubMed · cited 39
- Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinomaHan Wang et al. · EBioMedicine · 2024 · PubMed · cited 36
- Machine Learning-Based Prediction of Pediatric Ulcerative Colitis Treatment Response using Diagnostic HistopathologyXiaoxuan Liu et al. · Gastroenterology · 2024 · PubMed · cited 23
- A Review of Pharmacologic and Non-Pharmacologic Therapies in the Management of Irritable Bowel Syndrome: Current Recommendations and EvidenceAnthony J. Papale et al. · Journal of Clinical Medicine · 2024 · PubMed · cited 22
- New insights into biomarkers and risk stratification to predict hepatocellular cancerKechun Li et al. · Molecular Medicine · 2025 · PubMed · cited 19
- Endoscopic devices and techniques for the management of gastric varices (with videos)Guru Trikudanathan et al. · Gastrointestinal Endoscopy · 2024 · PubMed · cited 17